C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.38 AUD 0.73% Market Closed
Market Cap: 153.4m AUD
Have any thoughts about
Cyclopharm Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Cyclopharm Ltd

Current Assets 47.1m
Cash & Short-Term Investments 27.6m
Receivables 8.3m
Other Current Assets 11.2m
Non-Current Assets 17m
PP&E 10.4m
Intangibles 5.8m
Other Non-Current Assets 833.7k
Current Liabilities 10.7m
Accounts Payable 6.1m
Other Current Liabilities 4.7m
Non-Current Liabilities 5.8m
Long-Term Debt 4.7m
Other Non-Current Liabilities 1.1m

Balance Sheet
Cyclopharm Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
3
6
5
9
6
13
2
29
20
12
Cash
0
0
0
0
0
13
2
29
20
12
Cash Equivalents
3
6
5
9
6
0
0
0
0
0
Total Receivables
3
4
4
5
6
4
9
8
8
8
Accounts Receivables
3
4
4
5
6
4
5
5
5
6
Other Receivables
0
0
0
0
0
1
4
3
2
2
Inventory
2
2
3
3
3
2
5
6
8
10
Other Current Assets
0
0
0
0
1
0
0
0
1
0
Total Current Assets
9
13
11
17
15
20
16
43
37
30
PP&E Net
1
1
2
3
2
6
6
6
7
9
PP&E Gross
0
0
0
0
0
6
6
6
7
9
Accumulated Depreciation
0
0
0
0
0
15
16
16
16
13
Intangible Assets
1
1
2
3
5
4
4
5
5
5
Goodwill
0
0
0
0
0
1
1
1
1
1
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
1
1
1
1
1
1
1
1
1
1
Other Assets
0
0
0
0
0
1
1
1
1
1
Total Assets
11
N/A
17
+51%
16
-1%
23
+42%
24
+1%
33
+38%
28
-13%
56
+97%
50
-11%
46
-7%
Liabilities
Accounts Payable
2
2
3
3
4
3
4
4
6
6
Accrued Liabilities
0
0
0
0
0
1
1
1
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
1
1
1
3
1
0
0
3
2
3
Total Current Liabilities
3
3
4
5
5
3
6
7
8
9
Long-Term Debt
0
0
0
0
0
5
5
4
4
4
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
1
1
1
1
1
1
1
Total Liabilities
3
N/A
3
+7%
4
+15%
6
+55%
7
+6%
9
+43%
11
+20%
13
+14%
13
+3%
14
+5%
Equity
Common Stock
15
15
15
22
22
32
32
63
63
64
Retained Earnings
7
2
2
4
4
8
14
19
26
31
Other Equity
1
0
1
1
1
1
1
1
1
1
Total Equity
8
N/A
13
+69%
12
-5%
17
+38%
17
-1%
23
+36%
17
-26%
43
+152%
37
-15%
32
-12%
Total Liabilities & Equity
11
N/A
17
+51%
16
-1%
23
+42%
24
+1%
33
+38%
28
-13%
56
+97%
50
-11%
46
-7%
Shares Outstanding
Common Shares Outstanding
58
60
60
68
69
78
80
93
93
94

See Also

Discover More